Sebastian Filippas-Ntekouan1, Evangelos Liberopoulos2, Moses Elisaf1. 1. Department of Internal Medicine, University of Ioannina School of Health Sciences-Faculty of Medicine, 45 110, Ioannina, Greece. 2. Department of Internal Medicine, University of Ioannina School of Health Sciences-Faculty of Medicine, 45 110, Ioannina, Greece. vaglimp@yahoo.com.
Abstract
INTRODUCTION: Acute infections lead to significant alterations in metabolic regulation including lipids and lipoproteins, which play a central role in the host immune response. In this regard, several studies have investigated the role of lipid levels as a marker of infection severity and prognosis. SCOPE OF REVIEW: We review here the role of lipids in immune response and the potential mechanisms underneath. Moreover, we summarize studies on lipid and lipoprotein alterations in acute bacterial, viral and parasitic infections as well as their diagnostic and prognostic significance. Chronic infections (HIV, HBV, HCV) are also considered. RESULTS: All lipid parameters have been found to be significantly dearranged during acute infection. Common lipid alterations in this setting include a decrease of total cholesterol levels and an increase in the concentration of triglyceride-rich lipoproteins, mainly very low-density lipoproteins. Also, low-density lipoprotein cholesterol, apolipoprotein A1, low-density lipoprotein cholesterol and apolipoprotein-B levels decrease. These lipid alterations may have prognostic and diagnostic role in certain infections. CONCLUSION: Lipid testing may be of help to assess response to treatment in septic patients and those with various acute infections (such as pneumonia, leptospirosis and others). Diagnostically, new onset of altered lipid levels should prompt the clinician to test for underlying infection (such as leishmaniasis).
INTRODUCTION:Acute infections lead to significant alterations in metabolic regulation including lipids and lipoproteins, which play a central role in the host immune response. In this regard, several studies have investigated the role of lipid levels as a marker of infection severity and prognosis. SCOPE OF REVIEW: We review here the role of lipids in immune response and the potential mechanisms underneath. Moreover, we summarize studies on lipid and lipoprotein alterations in acute bacterial, viral and parasitic infections as well as their diagnostic and prognostic significance. Chronic infections (HIV, HBV, HCV) are also considered. RESULTS: All lipid parameters have been found to be significantly dearranged during acute infection. Common lipid alterations in this setting include a decrease of total cholesterol levels and an increase in the concentration of triglyceride-rich lipoproteins, mainly very low-density lipoproteins. Also, low-density lipoprotein cholesterol, apolipoprotein A1, low-density lipoprotein cholesterol and apolipoprotein-B levels decrease. These lipid alterations may have prognostic and diagnostic role in certain infections. CONCLUSION:Lipid testing may be of help to assess response to treatment in septicpatients and those with various acute infections (such as pneumonia, leptospirosis and others). Diagnostically, new onset of altered lipid levels should prompt the clinician to test for underlying infection (such as leishmaniasis).
Authors: P N Duchateau; C R Pullinger; R E Orellana; S T Kunitake; J Naya-Vigne; P M O'Connor; M J Malloy; J P Kane Journal: J Biol Chem Date: 1997-10-10 Impact factor: 5.157
Authors: Peter Jarcuska; Sylvia Drazilova; Jan Fedacko; Daniel Pella; Martin Janicko Journal: World J Gastroenterol Date: 2016-01-07 Impact factor: 5.742
Authors: Zhili Yao; Jessica M Mates; Alana M Cheplowitz; Lindsay P Hammer; Andrei Maiseyeu; Gary S Phillips; Mark D Wewers; Murugesan V S Rajaram; John M Robinson; Clark L Anderson; Latha P Ganesan Journal: J Immunol Date: 2016-08-17 Impact factor: 5.422
Authors: Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren Journal: Atherosclerosis Date: 2016-09 Impact factor: 5.162
Authors: Biao Lu; Arthur Moser; Judy K Shigenaga; Carl Grunfeld; Kenneth R Feingold Journal: Biochem Biophys Res Commun Date: 2009-12-31 Impact factor: 3.575
Authors: Zahedi Mujawar; Honor Rose; Matthew P Morrow; Tatiana Pushkarsky; Larisa Dubrovsky; Nigora Mukhamedova; Ying Fu; Anthony Dart; Jan M Orenstein; Yuri V Bobryshev; Michael Bukrinsky; Dmitri Sviridov Journal: PLoS Biol Date: 2006-10 Impact factor: 8.029
Authors: Amie J Eisfeld; Peter J Halfmann; Jason P Wendler; Jennifer E Kyle; Kristin E Burnum-Johnson; Zuleyma Peralta; Tadashi Maemura; Kevin B Walters; Tokiko Watanabe; Satoshi Fukuyama; Makoto Yamashita; Jon M Jacobs; Young-Mo Kim; Cameron P Casey; Kelly G Stratton; Bobbie-Jo M Webb-Robertson; Marina A Gritsenko; Matthew E Monroe; Karl K Weitz; Anil K Shukla; Mingyuan Tian; Gabriele Neumann; Jennifer L Reed; Harm van Bakel; Thomas O Metz; Richard D Smith; Katrina M Waters; Alhaji N'jai; Foday Sahr; Yoshihiro Kawaoka Journal: Cell Host Microbe Date: 2017-11-16 Impact factor: 21.023
Authors: Mohammad M Banoei; Hans J Vogel; Aalim M Weljie; Sachin Yende; Derek C Angus; Brent W Winston Journal: Crit Care Date: 2020-07-27 Impact factor: 9.097
Authors: Lluís Masana; Eudald Correig; Daiana Ibarretxe; Eva Anoro; Juan Antonio Arroyo; Carlos Jericó; Carolina Guerrero; Marcel la Miret; Silvia Näf; Anna Pardo; Verónica Perea; Rosa Pérez-Bernalte; Núria Plana; Rafael Ramírez-Montesinos; Meritxell Royuela; Cristina Soler; Maria Urquizu-Padilla; Alberto Zamora; Juan Pedro-Botet Journal: Sci Rep Date: 2021-03-30 Impact factor: 4.379